Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

5.41
Delayed Data
As of Jul 21
 -0.16 / -2.87%
Today’s Change
2.95
Today|||52-Week Range
9.25
-14.53%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Baker Bros Advisors Lp
Sale8/12/20162,834,561$5.00$14.2M+7.34%
Baker Bros Advisors Lp
Sale8/12/2016465,439$5.00$2.3M+7.34%
Baker Bros Advisors Lp
Sale8/15/2016343,583$4.83$1.7M+14.62%
Baker Bros Advisors Lp
Sale8/12/2016296,856$5.25$1.6M+7.34%
Baker Bros Advisors Lp
Sale8/15/201656,417$4.83$272.5K+14.62%
Baker Bros Advisors Lp
Sale8/12/201648,744$5.25$255.9K+7.34%
Babu Yarlagadda S
Sale8/25/201630,000$4.06$121.8K+31.95%
Staab Thomas R Ii
Chief Financial Officer & Senior Vice President
Sale3/16/201712,308$8.80$108.3K-38.52%
Staab Thomas R Ii
Chief Financial Officer & Senior Vice President
Buy3/16/201723,955$3.78$90.5K-38.52%
Staab Thomas R Ii
Chief Financial Officer & Senior Vice President
Sale8/09/201614,577$4.43$64.6K+9.29%
Page of 5